|

EC to docetaxel or paclitaxel Clinical Trials

1 actively recruiting trial

Also known as: Taxol

Pipeline

Phase 3: 1

Top Sponsors

  • RenJi Hospital1

Indications

  • Invasive Duct Carcinoma of Breast1
  • Mucinous Breast Cancer1
  • Tubular Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.